title: Darbepoetin alfa controversies, from dosage issues to safety concerns: the larger lesson.
authors.affiliation: University of California Los Angeles (UCLA) School of Medicine, UCLA Oncology Center, LosAngeles, California, USA.
authors.forename: John A
authors.initials: JA
authors.lastname: Glaspy
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications; D016032:Randomized Controlled Trials as Topic
chemical_list: D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa